DRKS00029024
Completed
Phase 2
Delving in the behavioural and neural correlates of pain perception using a therapy combining mindfulness meditation and transcranial direct current stimulation for the treatment of fibromyalgia syndrome. - Med_tDCS_Fibro
niversitätsmedizin Göttingen0 sites44 target enrollmentMay 31, 2022
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- M79.7
- Sponsor
- niversitätsmedizin Göttingen
- Enrollment
- 44
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Stable disease for at least 6 months prior to participation
- •2\. No new treatment approaches over the preceding 3 months
- •3\.Stable allowed fibromyalgia related medications (see below) for \= 4 weeks prior to the
- •study. List of allowed medications:
- •\-Intake of NSAIDs and coxibs as required (bei Bedarf), but participants must not take it 24
- •hours prior to study visits.
- •\- Commonly used antidepressants for FMS will be allowed.
- •\-Low dose (\<25 mg THC content/day) of medical oromucosal cannabinoid therapy (e.g.
- •dronabinol, nabiximols, extracts). The participant has to refrain from taking it up to 24 hours
- •prior to study visits.
Exclusion Criteria
- •1\. Treatment with any of the following medications:
- •\- Strong opioids, or taking more than three medications for fibromyalgia symptom relief.
- •\- Carbamazepine, benzodiazepines, phenytoin, gabapentin, pregabalin; calcium channel
- •antagonists (e.g. flunarizine), NMDA receptor antagonists (e.g. dextromethorphan, memantine),
- •anticholinergics.
- •\- Therapeutic local anesthetic infiltration of the spinal column within the last 4 weeks
- •before baseline and/or planned during the trial period.
- •\- Topically administered medication with influence on the study target during the study
- •Inhaled or smoked cannabinoids for medical use.
- •2\. presence of any major, acute or unstable medical, neurological or psychiatric disorder,
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
eural mechanism of behavioral and neurophysiological changed by sensorimotor incongruence.Healthy subjectsJPRN-UMIN000023526Kio University30
Completed
Not Applicable
Behavioral and neural underpinnings of positive and negative treatment expectations, and their effects on paiHealthy volunteersDRKS00031993niversitätsklinikum Essen, Klinik für Neurologie81
Not yet recruiting
Not Applicable
Investigating psychological and neural basis of intention to recommend campaign informatiohealthy subjectsJPRN-UMIN000024573IDAC, Tohoku University50
Completed
Not Applicable
Acupuncture-induced changes on brain excitability for stroke patients with motor dysfunctioMotor dysfunction after strokeNervous System DiseasesISRCTN13358253Beijing Hospital of Traditional Chinese Medicine40
Suspended
Not Applicable
Exploration of the neuronal and physical correlates of the motivative attitude Mae-mukiHealthy adults([After March, 2024] and individuals suffering from Parkinson's disease)JPRN-UMIN000051755ational Institutes for Quantum Science and Technology600